Compumed 

$6.01
6
+$0.01+0.17% Wednesday 20:00

Statistics

Day High
6.01
Day Low
6.01
52W High
6.95
52W Low
1.95
Volume
200
Avg. Volume
-
Mkt Cap
7.73M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

26DecExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
0.02
0.11
0.21
0.3
Expected EPS
N/A
Actual EPS
0.1377

Financials

-0.85%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
15.09MRevenue
-128,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CMPD. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GE Aerospace
GE
Mkt Cap350.33B
General Electric, through its healthcare division, offers medical imaging, diagnostics, and patient monitoring systems, competing directly with Compumed's diagnostic solutions.
Koninklijke Philips N.V.
PHG
Mkt Cap25.72B
Philips is a leading technology company in health tech, offering products and services in imaging, diagnostics, and healthcare informatics that rival Compumed's offerings.
Siemens
SIEGY
Mkt Cap235.51B
Siemens Healthineers, a segment of Siemens AG, provides a broad range of medical technology and services, including diagnostic imaging and laboratory diagnostics, directly competing with Compumed.
Medtronic
MDT
Mkt Cap102.97B
Medtronic offers medical devices and technology that compete in the diagnostics and patient monitoring markets, areas where Compumed is also active.
Intuitive Surgical
ISRG
Mkt Cap145.58B
Intuitive Surgical, known for its da Vinci surgical systems, competes with Compumed in the broader healthcare technology market, particularly in innovative medical devices.
Boston Scientific
BSX
Mkt Cap69.72B
Boston Scientific manufactures medical devices used in various medical specialties, including diagnostics and patient monitoring, competing with Compumed's product range.
Abbott Laboratories
ABT
Mkt Cap153.59B
Abbott Laboratories offers a wide range of healthcare products including diagnostics and medical devices, directly competing with Compumed in several areas.
Stryker
SYK
Mkt Cap119.69B
Stryker is a medical technologies firm that competes with Compumed through its range of medical devices, including surgical equipment and patient monitoring systems.

About

CompuMed, Inc. functions as a dedicated provider of advanced telemedicine solutions tailored for organizational clients. The company extends vital clinical care services to both individual patients and various medical facilities internationally. Its primary specializations encompass telecardiology and teleradiology services. These enable healthcare institutions worldwide to connect in real-time with U.S. Board-Certified specialists, utilizing sophisticated cloud-based platforms and integrated medical equipment. Beyond these core areas, CompuMed offers extensive enterprise-level telemedicine frameworks. Its telecardiology portfolio includes a wide array of diagnostic interpretations for adult and pediatric patients, covering examinations such as electrocardiograms (ECG), echocardiograms, vascular studies, holter monitoring, nuclear cardiology assessments, and direct video consultations. In the realm of teleradiology, the company delivers expert image analysis, precise transcription, comprehensive reporting, secure data storage, and video consultations for modalities like Vscan, X-ray, ultrasound, mammography, computed tomography (CT), and magnetic resonance imaging (MRI). CompuMed also offers OsteoGram software, a specialized tool that integrates with both standard and digital X-ray systems to aid in the screening, diagnosis, and ongoing management of osteoporosis. Furthermore, the company supplies mobile ECG and ultrasound solutions, which grant patients direct and immediate access to its network of board-certified medical experts, in addition to providing various medical devices. Its clientele spans a diverse range of sectors, including organ procurement organizations, rural healthcare providers, and correctional healthcare facilities. CompuMed, Inc. was founded in 1973 and is based in Los Angeles, California.
Show more...
CEO
Mr. Lee Keddie
Employees
8
Country
United States
ISIN
US2049145012

Listings

0 Comments

Share your thoughts

FAQ

What is Compumed stock price today?
The current price of CMPD is $6.01 USD — it has increased by +0.17% in the past 24 hours. Watch Compumed stock price performance more closely on the chart.
What is Compumed stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Compumed stocks are traded under the ticker CMPD.
Is Compumed stock price growing?
CMPD stock has risen by +0.17% compared to the previous week, the month change is a -7.54% fall, over the last year Compumed has showed a +50.25% increase.
What is Compumed market cap?
Today Compumed has the market capitalization of 7.73M
What were Compumed earnings last quarter?
CMPD earnings for the last quarter are 0.14 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Compumed revenue for the last year?
Compumed revenue for the last year amounts to 15.09M USD.
What is Compumed net income for the last year?
CMPD net income for the last year is -128,000 USD.
How many employees does Compumed have?
As of June 20, 2026, the company has 8 employees.
In which sector is Compumed located?
Compumed operates in the Health & Wellness sector.
When did Compumed complete a stock split?
The last stock split for Compumed was on May 23, 2022 with a ratio of 1:25.
Where is Compumed headquartered?
Compumed is headquartered in Los Angeles, United States.